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Abstract 
Objectives: The objective of this study was to evaluate the prevalence of different Oral Mucosal diseases in Anxiety 
and Depression patients.
Material and Methods: A hospital based observational Study was conducted in the department of Psychiatry and 
department of Oral Medicine and Radiology. Patients who were diagnosed with Anxiety or Depression by the psy-
chiatrists using Hamilton Anxiety and Depression scale were subjected to complete oral examination to check for 
oral diseases like Oral Lichen Planus (OLP), Recurrent Aphthous Stomatitis (RAS), and Burning Mouth Syndrome 
(BMS). Equal number of control group subjects were also included.
Results: In this study statistically significant increase in the oral diseases in patients with anxiety and depression 
than the control group was recorded. Oral diseases were significantly higher in anxiety patients (20.86%) than in 
depression (9.04%) and control group patients (5.17%). In anxiety patients, the prevalence of RAS was 12%, OLP 
was 5.7%, and BMS was 2.87%. In depression patients, the prevalence of RAS was 4.02%, OLP was 2.01% and 
BMS was 3.01%. In control group the prevalence was 2.2%, 1.33% and 1.62% in RAS, OLP and BMS respecti-
vely. RAS and OLP were significantly higher in the younger age group (18-49) and BMS was seen between the age 
group of 50-77 years in both study and control groups.
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Introduction
Psychiatric disorders are considerably increasing in last 
few years and represent a major public health problem. 
Psychosomatic disorders account for 10% of the global 
burden of disease, and this is expected to rise to 15% by 
2020 (1). Anxiety and Depression are one of the most 
prevalent psychiatric diseases. These diseases causes 
physical and pathological changes in the body, oral ca-
vity not being a exception. Oral diseases with psycho-
somatic etiology have long been identified in medicine 
but so far these psychosomatic etiologies have not been 
confirmed. Since oral mucosa is extremely reactive to 
emotional influences like stress, anxiety and depression; 
oral diseases may arise as a direct expression of emo-
tions, or indirect result of psychological alterations (2,3). 
Emotional alterations can disturb hormonal, vascular 
and muscular functions, which may result in physiolo-
gic changes causing pain, burning sensation and ulcera-
tions.  Although wide spectrum of psychiatric disorders 
affects the orofacial region, unfortunately they often are 
unrecognized because of the common and limited nature 
of their presenting features (4-6).
Various researchers confirmed that, psychogenic disea-
ses like anxiety and depression causes physiologic chan-
ges resulting in the development of oral mucosal disea-
ses like OLP, RAS, BMS. The occurrence of these oral 
conditions in psychiatric patient has not been studied in 
a pool of unexplored population of Karnataka or in India 
as a whole; often the oral health of such patients is un-
dervalued. So, there is increasing need of understanding 
the distribution of these conditions in patients having 
psychiatric disorders.
Material and Methods 
The present hospital based observational Study was con-
ducted at the department of Psychiatry and department 
of Oral Medicine and Radiology in Mangalore over a 
period of six months. Patients reporting to psychiatry 
department for the first time, who were diagnosed of 
Anxiety or Depression by using Hamilton Anxiety and 
Depression scale by a senior psychiatrist, were subjec-
ted to complete oral examination by experienced Oral 
diagnostician. Equal numbers of controls were included 
in the study. The controls included were healthy indi-
viduals reported to the dental out patient section. Ethi-
cal clearance was obtained from the institutional ethical 
committee. The subjects of all the three groups participa-
Conclusions: The results of the present study showed a positive association between psychological alterations and 
changes in the oral mucosa, particularly conditions like OLP, RAS and BMS. Thus psychogenic factors like anxiety 
and depression may act as a risk factor that could influence the initiation and development of oral mucosal diseases. 
Hence psychological management should be taken into consideration when treating patients with these oral diseases.
Key words: Lichen planus, anxiety, depression, burning mouth syndrome, recurrent aphthous stomatitis.
ted voluntarily, signing a written consent form.  Subjects 
were divided according to age as Adult group [18 - 49 
years] and an Older group [50 - 77 years]. The clinical 
examination of the oral cavity was done following the 
WHO guidelines, under artificial illumination on a den-
tal chair, using a mouth mirror to check for OLP, RAS 
and BMS.
Inclusion criteria constituted of the subjects diagnosed 
with anxiety or depression within the age of 18-77 years. 
Exclusion criteria constituted of subjects with any syste-
mic diseases, using tobacco; Presence of local irritating 
factor [sharp cusp, overhanging restoration, calculus. 
etc]; and subjects under treatment with psychoactive 
drugs [antidepressants, sedative, narcotics].
The clinical diagnosis of the OLP was established by the 
presence of a bilaterally symmetrical lacelike gray-whi-
te, radiating reticular, annular, plaque-type lesions pre-
sent at the time of the examination. Clinically diagnosed 
OLP were subjected to histopathological examination 
for confirmation.
The diagnosis of RAS was based on the patient’s history 
and clinical findings. Patients reporting recurrent episo-
des of round, or ovoid ulcers surrounded by erythematous 
halo and each episodes of ulceration lasting for a few days 
to weeks were considered for the study.  The ulcers had to 
be present at the time of the clinical examination.
BMS was recognized when oral burning or pain symp-
toms, in the absence of detectable mucosal changes were 
present at the time of clinical examination.
Results
A total of 278 anxiety and 398 depression subjects and 
equal number of controls were included in the study. 
In 278 anxiety patients, 58 [20.86%] had oral diseases 
and out of 398 depression patients, 36 [9.04%] had oral 
diseases. Out of 676 individuals in control group, 35 
[5.17%] had oral diseases. There was significant increa-
se in oral diseases in anxiety patients [20.86%], depres-
sion [9.04%] than control group [5.17%].
Comparison of oral diseases in three groups by using 
chi square revealed highly statistically significant results 
between anxiety, depression patients and control group. 
Comparatively oral lesions are higher in anxiety patients 
than compared to depression patients and control group 
patients (Table 1).
- Prevalence of oral diseases in anxiety, depression and 
control group (Table 2):
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Groups
(Total patients)
% of patients with oral diseases Mean 
Rank
K – ANOVA p value
Anxiety (278) 20.86% (58 ) 599.96 56.253 0.000
    HSDepression (398) 8.79% (36) 679.85
Control (676) 5.17%  (35) 706.00
HS – Highly Significant, p<0.05
Table. 1. Comparison of oral diseases (overall) among different groups by using chi square.
Table 2. Prevalence of oral diseases in anxiety, depression and control group.
Oral disease Anxiety (Total 
patients - 278)
Depression(Total 
patients- 398)
Control group  
(Total patients - 676)
RAS 12%, 4.02%, 2.2%
OLP 5.7%, 2.01% 1.33%
BMS 2.87%. 3.01%.  1.62%
Table 3. Distribution of oral diseases depending on severity of anxiety and depression.
Oral disease Anxiety Depression
Mild Moderate Severe Mild Moderate Severe
RAS 8 (23.5%) 14 (41.1%) 12 (35.2%) 3(18.7%) 7(43.7%) 6(37.5%)
OLP 2 (12.5%) 6 (37.5%) 8 (50 %) 1(12.5%) 3(37.5%) 4(50%)
BMS 0 (0%) 2  (25%) 6 (75%) 1(8.3%) 4(33.3%) 7(58.3%)
Table 4. Gender wise distribution of oral diseases in anxiety, depression and control groups.
Oral disease Anxiety Depression Controls
Male Female Male Female Male Female
RAS 14(41.11%) 20(58.89%) 7(43.5%) 9(56.5%) 6(40%) 9(60%)
OLP 4 (25%) 12 (75%) 3(37.5%) 5(62.5%) 4(44.4%) 5(55.5%)
BMS 2 (25%) 6 (75%) 4(33.33) 8(66.66) 4(36.3%) 7(63.6%)
Table 5. Age wise distribution different oral diseases in anxiety, depression and control groups.
Oral disease Anxiety Depression Controls
18-49 years 50-77 years 18-49 years 50-77 years 18-49 years 50-77 years 
RAS 27(79.41%) 7 (20.58%) 13(81.25%) 3(18.75%) 11(73.3%) 4(26.3%)
OLP 13(81.25%) 3(18.75%) 5(62.5%) 3(37.5%) 6(66.6%) 3(33.3%)
BMS 3 (37.5%) 5 (62.5%) 5(41.6%) 7(58.3%) 4(36.3%) 7(63.3%)
In anxiety subjects, the prevalence of RAS was 12%, 
OLP was 5.7%, and BMS was 2.87%. In depression 
subjects, the prevalence of RAS was 4.02%, OLP was 
2.01% and BMS was 3.01%.  In control group the pre-
valence of RAS was 2.2%, OLP was 1.33% and BMS 
was 1.62%.
- Distribution of oral diseases depending on severity 
anxiety and depression (Table 3):
Patients with moderate and severe anxiety and depres-
sion had significantly higher oral diseases than mild 
anxiety and depression subject.
- Gender wise distribution of oral diseases in anxiety, 
depression and control group (Table 4):
In all three groups oral mucosal diseases were signifi-
cantly higher in female patients.
- Age wise distribution of oral diseases in anxiety, de-
pression and control group (Table 5):
In all the three groups, RAS and OLP were significantly 
seen between the age group of 18 - 49 years, and BMS is 
seen between the age group of 50-77 years.
Besides these three oral diseases, majority of the ps-
ychiatric patients also showed other oral diseases like 
Xerostomia, Herpes labialis, Myofasial pain dysfunction 
syndrome, Geographic tongue, Fissured tongue, Dys-
guesia, Bruxism, Atypical facial pain and Lip or Cheek 
bite, in order of decreasing prevalence.
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Discussion
Emotional factors have potential influence on the body; 
it causes pathological changes or subjective symptoms 
in normal oral mucosa. Several studies have attempted 
to elucidate the possible role of psychological state, 
emotional instability and personality modulation in pre-
cipitation of various oral diseases like RAS, OLP and 
BMS, but no studies are available on the prevalence 
of oral diseases in psychiatric conditions like Anxiety 
and Depression (2,4). It is proposed that psychological 
disturbances procreate the development and worsening 
of the oral diseases. Many researchers found that oral 
diseases frequently undergo periods of remissions and 
exacerbations that often clearly relate to the patients emo-
tional status (4). Since the oral tissues are highly reacti-
ve to psychological influences, oral symptoms are com-
mon psychosomatic manifestation. Psychological factors 
results in the alteration in the nervous system markers 
[Catecholamines; Adrenaline, Noradrenaline, and Dopa-
mine], Endocrine system markers [Cortical and Aldoste-
rone], and Immune system [T cells, B cells and Natural 
Killer cells, Immunoglobulin’s] resulting in the initiation/ 
pathogenesis of the oral disease (6). No previous studies 
are available to compare the prevalence of oral disea-
ses in psychological altered conditions like anxiety and 
depression. However many studies have evaluated the 
prevalence rate in general population. The difference 
in prevalence rates could be attributed to different de-
mographic variables, genetic factors and difference bet-
ween the racial groups. Many researchers evaluated the 
stress, anxiety and depression levels in patients suffering 
from oral diseases. They concluded that significantly 
higher stress, anxiety and depression levels were found 
in the RAS, BMS and OLP patients when compared to 
controls (3,4,7,8). However many studies have assessed 
the prevalence of OLP in general population, in contrast, 
the present study evaluated the oral mucosal diseases 
in anxiety and depression patients which could explain 
higher prevalence of OLP in present study.
Suwarna Dangore-Khasbage et al. evaluated the pre-
valence of RAS, BMS, and OLP in institutionalized 
and non-institutionalized psychiatric patients, They 
found that the prevalence of RAS, BMS, and OLP was 
19.33%, 20.66% and 5.3%, respectively, in all psychia-
tric patients (1). In the present study prevalence rate 
was lesser because we considered only new anxiety and 
depression patients not under any previous medication. 
Authors also reports that the high prevalence of RAS, 
BMS and OLP in psychiatrist patients, can be due to 
increased psychological stress and psychiatric illness 
can modify immunological functions (9). Psychological 
investigations have reported that the oral mucosa is a 
complex and vulnerable region that is very reactive to 
certain psychological influences. Hence, on the basis of 
the available literature, the reasons for increased preva-
lence of RAS, BMS and OLP in psychiatric patients may 
be multiple and involve the interaction of biological and 
psychological systems (6).
Results of the present study are comparable to the fin-
dings of the previous studies in relation to the prevalen-
ce of oral diseases in general population.
B. E. McCartan et al. conducted comprehensive reviews 
of OLP in the period 1980-2007. An overall age standar-
dized prevalence of 1.27% [0.96% in men and 1.57% 
in women] was calculated from the study. They conclu-
ded that furthermore, well-designed studies, with agreed 
methodology and criteria, are required in a number of 
different populations for drawing strong conclusions on 
the prevalence of this condition (10). A more recent In-
dian study by Saraswathi T et al, reported a prevalence 
of  0.15% of OLP (11). Another latest survey by Mathew 
AL et al. reported a prevalence of 1.2% in Indian popu-
lation (8). Many previous studies reported prevalence of 
1 to 2% in general population (5,7). The prevalence rate 
of OLP in our study was found to be higher than reported 
by, the above mentioned researchers.
In the present study, the prevalence of RAS was 12%  in 
anxiety and 4.02% in depression patients, and 2.2% in 
control group suggesting a higher prevalence rate than 
that reported in the previous studies by  Mathew et al. in 
Indian normal population [2.01%], (8), Rivera-Hidalgo 
F et al. [0.89%] (12), Chattopadhyay in United States 
(13).  In a cross-sectional study by Mumcu G in Turkey 
population, RAS were observed in 1.2% of the exami-
ned patients (14). This is consistent with the results of 
the present study. This could be explained by that psy-
chiatric subjects might be different than other subjects in 
term of emotional alterations, stress, lifestyle and other 
related factors.
In regard to RAS, prevalence rate observed in the present 
study was lower than that reported by the previous studies. 
The occurrence of RAS in general population ranges bet-
ween 5% and 20% (5). Recent survey by Davatchi et al. in 
Tehran revealed a prevalence rate of 25.2% (15). Szponar 
E et al. in their 10-year retrospective observations in Iran 
reported a prevalence rate of 7.6% (16). A latest survey 
from Jordanian population reported a prevalence of about 
78% of subjects diagnosed with RAS (17).
The severity and frequency of the episodes vary on a 
case-by-case basis; however, it usually decreases with 
age. Many epidemiologic studies and our own observa-
tions confirmed the higher incidence of RAS in people 
with higher psychological alterations.
The recent study on the prevalence of RAS showed that 
the occurrence of RAS varies with the patient population 
depending on their ethnic origin and the diagnostic crite-
ria system accepted in different research centers. The ac-
tual prevalence rate of RAS is greater than the reported 
rates because of the recurrent nature of the condition and 
cross-sectional clinical surveys might probably under-
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estimate the true prevalence rate because active lesions 
may not be present at the time of examination (5,7).
The prevalence of BMS in anxiety patients were 2.87%; 
while depression patients showed a prevalence rate of 
3.01% with control group showing a 1.62% prevalence 
rate.
The prevalence rate of BMS observed in the present stu-
dy was higher than reported by Lipton JA, Ship 0.7% 
(18). Bergdahl and Anneroth 0.8%, (19). but lower than 
that reported by Basker Hakeberg M, 4.6%. (20) Berg-
dahl M, Bergdahl J, 3.7% (21). Femiano F, 13% (22), 
Savage NW  (23) and  Scala A (24).
The prevalence of BMS appears to be inaccurately esti-
mated because of inappropriate and lack of universally 
accepted diagnostic criteria. The lower prevalence of 
BMS in this study may be attributed to the wide age ran-
ge of patients in both sexes. When BMS was identified 
only on the basis of a prolonged burning sensation of the 
oral mucosa, a prevalence rate of 14.8% was estimated 
(25). However, when diagnosis was arrived at by the use 
of more correct criteria, BMS prevalence fell to 0.8% 
(19). In present study psychological component in BMS 
has been clearly identified. This is supported by studies 
that report greater levels of depression and anxiety in 
patients with BMS compared to control groups.
Conclusions
Oral health is important for patients with special needs 
such as psychiatric patients. The results of the present 
study provides an information on the distribution of oral 
mucosal diseases in psychiatric and general population. 
Oral lesions are significantly seen higher in individuals 
with anxiety and depression than the normal healthy in-
dividuals with sound mind and body. It is the responsi-
bility of the oral health provider to effectively provide 
adequate dental treatment for people with psychiatric di-
sabilities. Hence as an adjuvant to conventional therapy 
in these patients, psychiatric analysis and intervention 
should be considered while treating these oral diseases.
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